Glargine | Glargine | Glargine | p | |
---|---|---|---|---|
+ Lispro | + Exenatide | |||
Vascular outcomes after 8-week intervention | ||||
Baseline-adjusted systolic BP at 8-weeks (mmHg) | 130 (2.7) | 133 (2.7) | 128 (2.6) | 0.38 |
Baseline-adjusted diastolic BP at 8-weeks (mmHg) | 79 (1.7) | 81 (1.7) | 78 (1.7) | 0.34 |
Baseline-adjusted heart rate at 8-weeks (bpm) | 71 (1.6) | 72 (1.7) | 71 (1.6) | 0.91 |
Baseline-adjusted RHI at 8-weeks | 2.07 (0.10) | 2.00 (0.10) | 1.81 (0.10) | 0.19 |
Vascular outcomes after 3-month washout | ||||
Baseline-adjusted systolic BP at 20-weeks (mmHg) | 133 (2.1) | 132 (2.0) | 128 (1.9) | 0.25 |
Baseline-adjusted diastolic BP at 20-weeks (mmHg) | 83 (1.6) | 81 (1.5) | 79 (1.5) | 0.28 |
Baseline-adjusted heart rate at 20-weeks (bpm) | 70 (1.6) | 72 (1.6) | 69 (1.5) | 0.53 |
Baseline-adjusted RHI at 20-weeks | 1.74 (0.10) | 1.87 (0.09) | 1.96 (0.09) | 0.25 |